CDH1 and neoplasm: Therefore, we used a stemness gene associated with tumor cell heterogeneity and SOX2, SOX4, SOX9, basal cell markers KRT5, KRT14, immune genes PD-Ll and epithelial-mesenchymal transition E-cadherin to study heterogeneous cell and malignant transformation mechanisms.